Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
CA 2335858 A1 · Owner: Medinox, Inc. · Inventors: Vassilev, Vassil; Lai, Ching-San
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a novel dithiocarbamate disulfide dimer useful in various therapeutic treatments, either alone or in combination with other active agents. In one method, the disulfide derivative of a dithiocarbamate is coadministered with an agent that inactivates (or inhibits the production of) species that induce the expression of nitric oxide synthase to reduce the production of such species, while, at the same time reducing nitric oxide levels in the subject. In another embodiment free iron ion levels are reduced , in a subject by administration of a disulfide derivative of a dithiocarbamate(s) to scavenge free iron ions for example, in subjects , undergoing …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 22, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 22, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 22, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.